Scientific evidence suggesting that three-dimensional conformal radiotherapy, as well as IMRT, may be helpful to minimize normal tissue structure involvement and to contribute to a lower toxicity maintaining or increasing the therapeutic efficacy is still limited. There is still no information coming from controlled clinical trials with harder endpoints (mortality, disease-free survival, quality of life, acute and immediate toxicity) to be able to assess its relative efficacy and cost-effectiveness.